1. Traynelis SF, Lipton SA. Is tissue plasminogen activator a threat to
neurons? Nat Med. 2001;7:17–18.
2. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA. 16.
Tissue plasminogen activator (tPA) increases neuronal damage after focal
cerebral ischemia in wild-type and tPA-deficient mice. Nat Med. 1998;
4:228 –231. 17.
3. Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET,
Vivien D, Buisson A. The proteolytic activity of tissue-plasminogen
activator enhances NMDA receptor-mediated signaling. Nat Med. 2001; 18.
7:59–64.
4. Kilic E, Hermann DM, Hossmann K-A. Recombinant tissue plasminogen 19.
activator reduces infarct size after reversible thread occlusion of middle
cerebral artery in mice. Neuroreport. 1999;10:107–111.
5. Kilic E, Hermann DM, Hossmann K-A. Recombinant tissue-plasminogen
activator-induced thrombolysis after cerebral thromboembolism in mice. 20.
Acta Neuropathol (Berl). 2000;99:219 –222.
6. Klein GM, Li H, Sun P, Buchan AM. Tissue plasminogen activator does
not increase neuronal damage in rat models of global and focal ischemia. 21.
Neurology. 1999;52:1381–1384.
22.
7. Meng W, Wang X, Asahi M, Kano T, Asahi K, Ackerman RH, Lo EH.
Effects of tissue type plasminogen activator in embolic versus mechanical
23.
models of focal cerebral ischemia in rats. J Cereb Blood Flow Metab.
1999;19:1316 –1321.
8. Tabrizi P, Wang L, Seeds N, McComb JG, Yamana S, Griffin JH,
Carmeliet P, Weiss MH, Zlokovic BV. Tissue plasminogen activator
24.
(tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain
injury in a murine stroke model: studies in tPA-deficient mice and
wild-type mice on a matched genetic background. Arterioscler Thromb
25.
Vasc Biol. 1999;19:2801–2806.
9. Vivien D, Buisson A. Serine protease inhibitors: novel therapeutic targets
for stroke? J Cereb Blood Flow Metab. 2000;20:755–764.
10. Hata R, Mies G, Wiessner C, Hossmann KA. A reproducible model of
26.
middle cerebral artery occlusion in mice: hemodynamic, biochemical and
magnetic resonance imaging. J Cereb Blood Flow Metab. 1998;18:
367–375.
11. Hata R, Maeda K, Hermann D, Mies G, Hossmann KA. Dynamics of 27.
regional brain metabolism and gene expression after middle cerebral
artery occlusion in mice. J Cereb Blood Flow Metab. 2000;20:306 –315.
12. Hata R, Maeda K, Hermann DM, Mies G, Hossmann KA. Evolution of
brain infarction after transient focal cerebral ischemia in mice. J Cereb
Blood Flow Metab. 2000;20:937–946. 28.
13. Hermann DM, Kilic E, Hata R, Hossmann K, Mies G. Relationship
between metabolic dysfunctions, gene responses and delayed cell death
after mild focal cerebral ischemia in mice. Neuroscience. 2001;104: 29.
947–955.
